Literature DB >> 1330971

Phase II trial of N-methylformamide in lung cancer.

R L Cody1, J E Seid, R B Natale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1330971     DOI： 10.1007/bf00877249

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  5 in total

1.  Decreased membrane fluidity during differentiation of human promyelocytic leukemia cells in culture.

Authors:  S H Ip; R A Cooper
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

Review 2.  Polar solvents: a novel class of antineoplastic agents.

Authors:  E N Spremulli; D L Dexter
Journal:  J Clin Oncol       Date:  1984-03       Impact factor: 44.544

3.  Phase II trial of N-methylformamide in advanced head and neck cancer.

Authors:  W C Vogel; A A Forastiere; R B Natale; B J Takasugi; G Schnur
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

4.  N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells.

Authors:  D L Dexter; J A Barbosa; P Calabresi
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

5.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.